The Asia Pacific Resveratrol Market would witness market growth of 10.6% CAGR during the forecast period (2021-2027).
Resveratrol refers to a chemical compound, commonly found in grapes, plums, blueberries, peanuts, and apples. This compound contains cardioprotective, anti-inflammatory, antioxidant, and anti-cancer properties, which make it an important compound for human health that helps the human body in improving various biological activities.
The supportive policies of the governments across various nations of the region are encouraging several key market players to expand their footprints in this region. The changing lifestyle and food patterns of the consumers in this region would fuel the demand for dietary supplements and thus, augmenting the growth of the regional resveratrol market. There is an increase in the applications of resveratrol in the various industries including cosmetic, pharmaceutical, and other in this region, which is estimated to fuel the growth of the regional resveratrol market during the forecast period.
The China market dominated the Asia Pacific Resveratrol Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $9,247.4 Thousands by 2027, growing at a CAGR of 8.5 % during the forecast period. The Japan market is expected to witness a CAGR of 9.6% during (2021 - 2027). Additionally, The India market is expected to witness a CAGR of 11.1% during (2021 - 2027).
Based on Product Type, the market is segmented into Natural Resveratrol and Synthetic Resveratrol. Based on Application, the market is segmented into Nutraceuticals, Pharmaceuticals, Cosmetics and Other Applications. Based on Form, the market is segmented into Liquid and Powder. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Resveratrol Market is Projected to reach USD 129.4 Million by 2027, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Evolva Holding SA, Sabinsa Corporation, Lonza Group AG, Maypro, Laurus Labs Limited, JF Natural, Great Forest Biomedical Ltd. and Chengdu Yazhong Bio-pharmaceutical Co., Ltd.
By Product Type
By Application
By Form
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 